Program Portfolios by CSO Categories
The International Cancer Research Partnership was formed in 2000 and is an active network of senior representatives from organizations united in a collaborative effort to promote coordinated progress in cancer research. Currently, the ICRP consists of cancer research funding organizations within the United States, Canada, Europe, Australia and Japan who have agreed to apply a common language-the Common Scientific Outline (CSO)-for discussing, comparing, and presenting their cancer research portfolios. The CSO classification system provides the tools needed to lay the groundwork for collective portfolio analyses and coordinated strategic planning among the Partner organizations.
ICRP members represent some of the largest funders of cancer research in the world. Members share award funding data in a common format to allow comparisons across all organizations. Part of the dataset is made available to the public (https://www.icrpartnership.org/database.cfm) and contributing partners have full access in a password-protected site.
The Common Scientific Outline, or CSO, is a classification system organized around seven broad areas of scientific interest in cancer research:
- Biology
- Etiology (causes of cancer)
- Prevention
- Early Detection, Diagnosis, and Prognosis
- Treatment
- Cancer Control, Survivorship, and Outcomes Research
- Scientific Model Systems
Breast Cancer |
Lung Cancer |
Ovarian Cancer |
Peer Reviewed Cancer |
Prostate Cancer |